Radio Frequency Ablation (RFA)

Radio Frequency Ablation (RFA) is a new technique for treating tumors localized to certain organs such as the liver, kidney and lungs.  With this technique, relatively small probes are placed into the tumor and radio frequency (RF) energy deposited. The RF energy causes the tissue around the tip of the probe to heat up to a temperature where cells break apart and die.  Since RF kills both tumor and non-tumor cells, the goal is to place the probes so that they destroy all of the tumor plus an adequate "rim" of non-tumorous tissue around it.

During a Radio Frequency Ablation procedure, the doctor places a slender probe directly into the tumor. Arrays of several small, curved electrodes are deployed from the end of the probe into the tissue. The generator is turned on and target temperatures are entered. The radio frequency energy flows through the electrodes, causing ionic agitation, and therefore friction, in the nearby tissue. This friction creates heat which kills and destroys the tumor.

There are several different ways that a RFA procedure may be performed which your doctor will help you decide depending on the type and size of tumors, their number and location, the severity of the disease, and your general health. One option is a percutaneous approach. With this approach, a needle-sized electrode is passed directly through the skin and guided into place. This requires only light sedation and you can go home the same day. Another option is a laparoscopic approach. With this approach, several tiny incisions are made, allowing the insertion of the RFA and imaging probes. This requires general anesthesia and you can usually go home the next day. A third option is open surgery. With this approach the RFA can be used during open surgery, allowing the doctor to view the tumor before and during treatment. This requires general anesthesia and a slightly longer recovery.

Benefits:

Risks:

RFA -Vantage Mobile- and the RITA System
A Minimally Invasive Treatment Option
for Liver and Bone Lesions

Our patented electrosurgical delivery method, known as The RITA System uses deployable radiofrequency (RFA) electrode arrays to raise the temperature of cells above 45 to 50°C and cause cellular death.

More Options. More Control.
Used by surgical oncologists, hepatobiliary surgeons, liver transplant surgeons, laparoscopists and interventional radiologists, the RITA System offers patients with unresectable liver lesions an effective treatment option with few side effects or complications. The RITA System is also cleared for use as a pain relief method for patients with metastatic bone lesions.

StarBurst Electrosurgical Devices
Our disposable devices are monopolar electrodes capable of monitoring direct tissue temperatures and impedance from the ablation site. Using automatic temperature control, the devices are able to effectively destroy the entire targeted area.


For details, contact Bill Henwood 800-715-1214 or billh@vantagehealthcare.com

 

Brochure [pdf]

All print materials are in pdf format. You will need
Adobe Acrobat Reader to view. Download a free copy

For more information on RFA, please fill out the following form and we will contact you.

Name
Title
Organization
Street Address
Address (cont.)
City
State
Zip Code
Phone
FAX
E-mail
   
Comments:
   
 

Information submitted will only be used by Vantage® for your specific inquiry. Information submitted will not be shared outside of Vantage® without your permission. Vantage® does not rent, sell or lease customer information to third parties.